Related references
Note: Only part of the references are listed.Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial
Masakazu Abe et al.
SUPPORTIVE CARE IN CANCER (2016)
Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study
K. Suzuki et al.
ANNALS OF ONCOLOGY (2016)
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
F. Roila et al.
ANNALS OF ONCOLOGY (2016)
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Rudolph M. Navari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A double-blind randomized phase II study of 10 versus 5 mg olanzapine for emesis induced by highly emetogenic chemotherapy with cisplatin.
Hironobu Hashimoto et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
A double-blind randomized Phase II study of olanzapine 10 mg versus 5 mg for emesis induced by highly emetogenic chemotherapy
Kengo Nagashima et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Randomized, Double-Blind, Placebo-Controlled Study
Naomi Mizukami et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2014)
The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
Rudolph M. Navari et al.
SUPPORTIVE CARE IN CANCER (2013)
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Ethan Basch et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Lijun Tan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study
Rudolph M. Navari et al.
SUPPORTIVE CARE IN CANCER (2007)
A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A Hoosier Oncology Group study
RM Navari et al.
SUPPORTIVE CARE IN CANCER (2005)
A phase I trial of olanzapine (zyprexa) for the prevention of delayed emesis in cancer patients: A Hoosier Oncology Group Study
SD Passik et al.
CANCER INVESTIGATION (2004)
Share Paper
